Implementing mHealth for Schizophrenia in Community Mental Health Settings
Part of paid clinical trials in Chehalis, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT04147897
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- FOCUS — DEVICEFOCUS is a self management mHealth application for people with serious mental illness.
Study Details
Randomized control trial examining two mHealth intervention strategies.
Key Dates
- Start date
- Jun 16, 2020
- Status verified
- Nov 2025
- Primary completion
- Sep 16, 2024
- Completion
- Sep 16, 2024
Study Design
- Enrollment
- 299 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Internal FacilitationmHealth specialist is a trained clinician embedded in the clinical team offering the mHealth intervention, FOCUS.
- Active Comparator: External FacilitationmHealth specialist is a trained clinician external to the clinical team offering the mHealth intervention, FOCUS.
Primary Outcome Measure
Patient Health Questionnaire (PHQ)-9 [ Time Frame: 0,3,6 months ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cascade Mental Health Care | Chehalis | Washington | 98532 | - |
| NEW Alliance Counseling Services | Colville | Washington | 99114 | - |
| Compass Health | Everett | Washington | 98201 | - |
| Valley Cities | Federal Way | Washington | 98003 | - |
| Peninsula Behavioral Health | Port Angeles | Washington | 98362 | - |
| Sound Health | Seattle | Washington | 98125 | - |
| Frontier Behavioral Health | Spokane | Washington | 99201 | - |
| Comprehensive Healthcare | Yakima | Washington | 98902 | - |
Find similar trials in Chehalis, WA
By condition
By specialty
Related Studies
- Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsPHASE3 · Enrolling By Invitation · Alkermes, Inc. · Dothan, Alabama
- Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderPHASE3 · Recruiting · Alkermes, Inc. · Dothan, Alabama
- An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaPHASE3 · Recruiting · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Phoenix, Arizona
- Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsPHASE4 · Recruiting · Vanda Pharmaceuticals · Little Rock, Arkansas